SPR Biosensors: Diverse Applications, Transformative Impact
Received: 03-Nov-2025 / Manuscript No. jabt-25-177843 / Editor assigned: 05-Nov-2025 / PreQC No. jabt-25-177843 / Reviewed: 19-Nov-2025 / QC No. jabt-25-177843 / Revised: 24-Nov-2025 / Manuscript No. jabt-25-177843 / Published Date: 01-Dec-2025 DOI: 10.4172/2155-9872.1000818
Abstract
Surface plasmon resonance (SPR) biosensors represent a rapidly evolving technology with profound applications across medical diagnostics, environmental monitoring, food safety, and drug discovery. These sensors leverage label-free, real-time analysis for highly sensitive detection. Recent innovations include integrating advanced materials such as graphene and plasmonic nanostructures to enhance performance, as well as developing localized SPR imaging for cellular analysis. The emergence of portable and miniaturized SPR devices is extending advanced diagnostic capabilities to point-of-care settings, emphasizing their critical role in transforming diverse scientific and clinical fields through rapid and accessible detection
Keywords: Surface Plasmon Resonance; Biosensors; Disease Detection; Graphene; Plasmonic Nanostructures; Label-Free Analysis; Environmental Monitoring; Food Safety; Drug Discovery; Point-of-Care Diagnostics
Introduction
Surface plasmon resonance (SPR) biosensors are critical for early disease detection, significantly improving treatment outcomes. This technology provides label-free, real-time analysis by exploiting refractive index changes. SPRs versatility allows its application across diverse medical fields, including oncology and infectious diseases, promising to revolutionize diagnostics through rapid and highly specific data acquisition, transforming modern healthcare. [1].
Integrating graphene significantly boosts the sensitivity of SPR biosensors. Graphenes exceptional optical and electrical properties enhance the interaction between the analyte and plasmonic field, enabling highly sensitive detection platforms. This synergy facilitates identifying biomolecular interactions even at extremely low concentrations, which is vital for applications requiring minute detection limits in both research and clinical settings, advancing precision diagnostics. [2].
Localized surface plasmon resonance (LSPR) imaging offers a powerful, non-invasive method for label-free analysis of complex cellular processes. It provides direct insights into real-time cellular dynamics and cell-surface interactions, bypassing disruptive fluorescent tags. This innovative approach yields more accurate, biologically relevant data, simplifying experiments and reducing artifacts, marking significant advancement in biological studies. [3].
Surface plasmon resonance sensors are gaining traction for environmental monitoring, addressing the need for rapid, accurate pollutant detection. They identify diverse hazardous substances, including toxins and contaminants in water and air. Their real-time analytical power and sensitivity offer significant advantages over conventional methods. However, widespread field deployment requires overcoming technical hurdles related to sensor robustness and selectivity, remaining active research areas. [4].
Plasmonic nanostructures profoundly enhance surface plasmon resonance sensor performance, significantly boosting sensitivity and detection limits. By designing nanoscale architectures like nanoparticles, researchers harness localized electromagnetic fields that intensely amplify the SPR signal. This strategic enhancement is crucial for detecting minute analyte quantities across various biological and chemical sensing applications, driving superior analytical capabilities essential for advanced sensor development. [5].
SPR-based biosensors are highly impactful in medical diagnostics, providing versatile platforms for clinical applications such as pathogen detection, cancer biomarker quantification, and therapeutic drug monitoring. Their rapid response, label-free operation, and exceptional sensitivity make them invaluable in modern clinical settings. This technological prowess facilitates personalized medicine approaches, enabling tailored patient treatments based on precise diagnostic information. [6].
Theoretical and numerical analyses are foundational for advancing SPR biosensors, particularly those incorporating novel 2D materials. Computational investigations offer insights into how material properties and structural designs influence sensor sensitivity and efficiency. By employing advanced modeling, researchers accurately predict device behavior, optimizing future SPR sensor configurations. This approach minimizes extensive experimental trials, streamlining development and accelerating high-performance sensing platforms. [7].
The application of SPR biosensors in food safety and quality monitoring represents a significant public health advancement. These sensors effectively detect contaminants like pesticides, heavy metals, and pathogens, and enable real-time food freshness assessment. Rapid, on-site detection is crucial for preventing foodborne illnesses and upholding stringent quality standards throughout the supply chain. [8].
SPR technology is invaluable for accelerating drug discovery and development. It offers unparalleled real-time, label-free analysis of molecular interactions, crucial for identifying potent drug candidates. SPR precisely characterizes binding kinetics and protein-ligand interactions, providing quantitative insights early in the pipeline. This streamlines optimization, leading to more efficient and cost-effective drug design, significantly impacting pharmaceutical research. [9].
Portable and miniaturized SPR biosensors mark a transformative shift in diagnostic accessibility, particularly for point-of-care (POC) applications. These compact devices extend advanced diagnostic capabilities beyond traditional laboratories, enabling rapid, accurate, on-site detection without bulky equipment. This critical development broadens the reach of sophisticated medical testing, facilitating quicker decisions and improved patient outcomes in diverse environments. [10].
Description
The fundamental principles of SPR biosensors involve exciting surface plasmons at a metal-dielectric interface, exquisitely sensitive to refractive index changes. Sophisticated design strategies optimize this sensitivity, maximizing signal-to-noise for enhanced detection accuracy. These biosensors are crucial for identifying disease biomarkers at low concentrations, key for early diagnosis. Their operational efficiency offers substantial advantages over conventional laboratory techniques. [1]. Graphene-based SPR biosensors leverage graphenes unique 2D structure to amplify signals, achieving superior detection. Its high surface-to-volume ratio and conductivity facilitate efficient immobilization of biorecognition elements and enhanced light-matter interaction. This improved design provides a robust response to analytes, invaluable for complex biomolecular interactions. Such enhanced capabilities extend utility across various sensing applications, where high sensitivity is crucial. [2]. LSPR imagings primary advantage is its real-time monitoring of cellular events without labeling. It provides granular details about dynamic processes like cellular adhesion and receptor-ligand binding at the cellular interface. By utilizing localized field enhancement around plasmonic nanoparticles, LSPR offers a direct, highly sensitive platform for observing subtle biological shifts, making it indispensable for understanding cellular biology and disease progression. [3]. SPR technology in environmental monitoring is rapidly evolving, providing robust platforms for detecting a wide array of pollutants. These sensors excel at identifying pesticides, heavy metals, and persistent organic pollutants, which threaten ecosystems and human health. Real-time data allows for immediate environmental quality assessment and rapid intervention. Complex matrices and need for cost-effective portable devices remain challenges. [4]. Plasmonic nanostructures represent a sophisticated approach to significantly improve SPR sensor capabilities. When illuminated, these structures generate highly localized surface plasmon resonance, creating intense electromagnetic field hot spots. This enhancement drastically increases interaction probability, boosting intrinsic sensitivity and lowering detection limits. Such engineering is essential for advancing biosensor technology, enabling trace molecule detection crucial for early diagnosis. [5]. The extensive application of SPR biosensors in medical diagnostics addresses diverse clinical needs. These sensors provide critical information for early identification of infectious agents and precise quantification of cancer biomarkers, enhancing patient care. For therapeutic drug monitoring, SPR offers real-time drug concentrations, ensuring optimal dosing. This broad spectrum of applications confirms SPR as a cornerstone technology for clinical diagnostics. [6]. Incorporating 2D materials into SPR biosensors demands robust theoretical and numerical analysis. Computational methods model light-matter interactions and plasmon excitation in hybrid structures. These analyses reveal how layer thickness, material composition, and geometric parameters affect sensor figures of merit. Such understanding guides experimental design, predicting optimal conditions, and ultimately fabricating more efficient SPR devices. [7]. SPR biosensors are indispensable for ensuring food supply chain integrity and safety. Their high specificity and sensitivity enable precise detection of minute quantities of harmful substances. Real-time, non-invasive food freshness monitoring is a critical advantage, reducing waste and improving logistics. Swift, accurate analytical results at the point of need empower proactive measures, mitigating contamination risks and safeguarding public health. [8]. The profound utility of SPR in the pharmaceutical industry stems from its ability to provide comprehensive insights into drug-target interactions. SPR facilitates high-throughput screening of compound libraries, identifying promising lead molecules. It precisely quantifies binding affinity and kinetics, vital for understanding drug efficacy. Offering a direct, label-free method, SPR reduces development time and resources, accelerating therapeutic agent delivery. [9]. Miniaturized and portable SPR biosensors lead innovation, revolutionizing point-of-care diagnostics by bringing sophisticated analytical power directly to patients. These devices integrate advanced SPR technology into compact formats, allowing rapid, on-site detection of biomarkers and pathogens. Performing complex analyses without specialized infrastructure empowers healthcare providers to make immediate, informed decisions. This accessibility enhances emergency response, improving global public health. [10].
Conclusion
Surface plasmon resonance (SPR) biosensors are critical tools across diverse fields, offering rapid, label-free, and highly sensitive detection capabilities. Recent advancements highlight their crucial role in early disease diagnosis and personalized medicine, with design strategies focusing on enhancing sensitivity and specificity. The integration of novel materials like graphene and plasmonic nanostructures significantly boosts sensor performance, enabling detection of biomolecular interactions at low concentrations. Localized SPR imaging provides non-invasive analysis of cellular processes, offering real-time insights without fluorescent tags. Beyond medical applications, SPR sensors are vital for environmental monitoring, detecting pollutants in water and air, and for ensuring food safety by identifying contaminants and monitoring freshness. Furthermore, SPR accelerates drug discovery by characterizing molecular interactions, binding kinetics, and protein-ligand dynamics in real time. The development of portable and miniaturized SPR biosensors is expanding advanced diagnostics into point-of-care settings, making high-sensitivity detection more accessible globally. These collective advancements underscore SPR technologys transformative impact on diagnostics, environmental science, food safety, and pharmaceutical research.
References
- F LW, W CL, H MC. (2023) .Biosens Bioelectron 223:115002.
, ,
- A KRN, S RS, V KS. (2022) .Opt Mater (Amsterdam) 128:112440.
, ,
- J YL, H SK, S WH. (2021) .ACS Sens 6:756-770.
, ,
- M HR, M AB, K S. (2020) .Sens Actuators B Chem 306:127521.
, ,
- T SH, X GW, Y JL. (2023) .Nanoscale 15:10986-11005.
, ,
- S LC, Y CL, C HC. (2020) .J Biomed Opt 25:070901.
, ,
- A MA, M AK, S SAZ. (2021) .Results Phys 23:103975.
, ,
- R SD, S S, R K. (2022) .Food Chem 375:131868.
, ,
- A AS, B GS, C DK. (2021) .J Pharm Biomed Anal 203:114227.
, ,
- K LW, C YC, Y HW. (2023) .TrAC Trends Anal Chem 160:116937.
, ,
Citation: Popov I (2025) SPR Biosensors: Diverse Applications, Transformative Impact. jabt 16: 818. DOI: 10.4172/2155-9872.1000818
Copyright: © 2025 Ivan Popov This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Open Access Journals
Article Tools
Article Usage
- Total views: 117
- [From(publication date): 0-0 - Apr 05, 2026]
- Breakdown by view type
- HTML page views: 83
- PDF downloads: 34
